DMAC - DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2019 Results - Earnings Call Transcript
DiaMedica Therapeutics Inc. (DMAC)
Q3 2019 Earnings Conference Call
November 14, 2019 08:00 ET
CompanyParticipants
Rick Pauls - President & CEO
Scott Kellen - CFO
Harry Alcorn - Chief Medical Officer
Conference Call Participants
Alex Nowak - Craig-Hallum Capital
Thomas Flaten - Lake Street Capital
Greg Bogdanski - Dougherty & Company
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to DiaMedica Therapeutics' Third Quarter 2019 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor section.
Before the company proceeds